Admin Control Panel

New Post | Settings | Change Layout | Edit HTML | Edit posts | Sign Out
MEBO Karen
at UK Findacure conf 2020

Scroll down and select country
MEBO TMAU TESTING DISCONTINUED
(2012-2017)

MEBO - UBIOME study 2018

'PRESS RELEASE'

NCT03582826
ClinicalTrials.gov

MEBO Gut Microbiome Study
"Microbial Basis of Systemic Malodor and PATM Conditions (PATM)"
Funded by uBiome Research Grant

"Microbial Basis of Systemic Malodor and PATM Conditions (PATM)"

Dynamics of the Gut Microbiota in
Idiopathic Malodor Production
& PATM

Started May 2018 - Ongoing

Current people sent kits : 100/100
3 kits per person

NO LONGER RECRUITING

Participation info : LINK English

MEBO Map Testing & Meetups


Full details : https://goo.gl/TMw8xu
want listed ? contact info@meboresearch.org

MEBO Private Facebook Group
to join : go to
or contact
Join/Watch the weekly
BO Sufferers Podcasts

MEBO TMAU Videos

Petitions

TMAU Petition world
TMAU UK end total:262
TMAU UK ends 23/01/20
TMAU Petition USA end total 204
USA : Moveon open
TMAU (Dominican)
Metabolomic Profiling Study
NCT02683876

Start : Aug 2016
Stage 1 : 27 Canadian volunteers to test
Latest click here (26 oct) :
17 samples returned


Note : Stage 1 is Canada only.
Return cut-off date : passed
Analysis can take 6/8 weeks
Analysis start in/before Nov
MEBO Research is a
EURORDIS and
NORD Member Organization
See RareConnect

Popular Posts (last 30 days)

Upcoming get-togethers


Let us know if you want a meetup listed

Subscribe to Blog

Enter your email address:

Delivered by FeedBurner

You will be sent a verification email

Subscribe in a reader

Blog Archive

MEBO Research Clinical Trials

Click here to read details of the MEBO Clinical Trials
NCT03582826 - Ongoing not recruiting
Microbial Basis of Systemic Malodor and PATM Conditions (PATM)
United States 2018 - ongoing

NCT02683876 - Completed
Exploratory Study of Relationships Between Malodor and Urine Metabolomics
Canada and United States 2016 - ongoing

NCT03451994 - Completed
Exploratory Study of Volatile Organic Compounds in Alveolar Breath
United Kingdom and United States 2013 - ongoing

NCT02692495 - Completed
Evaluation of Potential Screening Tools for Metabolic Body Odor and Halitosis
United Kingdom 2009 - 2012

Friday, August 3, 2012

Adverse drug reaction, metabolic deficiency & odor

DRUG ADVERSE REACTION TO ANESTHESIA
AND ODOR


On Tuesday, my younger son had knee surgery (ACL transplant, Lateral Meniscectomy, and Medial Meniscal Repair), with general anesthesia. His adverse reaction to the general anesthesia brought to mind Dr. Elizabeth Shephard’s PowerPoint presentation, FMO3 – a protein that can multi-task that she created for MEBO's annual Miami Beach Meetup/Conference. This PowerPoint features the importance of Pharmacogenetics & Personalized Medicine for persons with metabolic deficiencies that result in adverse drug reactions, and in some cases death.

My son’s adverse reaction involved uncontrollable vomiting of bile and tremors, since he is epileptic (see articles on TMA and epilepsy, learning disabilities, anxiety, and more). The biggest concern was that he would vomit during seizure activity resulting in choking and pulmonary aspiration of bile. So he was administered propofol to render him unconscious in hopes that when he would regain consciousness, this reaction would have subsided, but it did not. This adverse reaction lasted four hours, in spite of Sofran administered intraveneously numerous times. Thankfully, he never choked or aspirated bilious vomitus and his tremors subsided, although the nausea and lightheadedness has lasted four days up to now; and we will see how long these symptoms will linger.

The surgical staff was very concerned during this episode, and relieved after these symptoms subsided. They made it a point to explain to him that this reaction was not an allergy, but simply an adverse reaction to anesthesia. The anesthesiologist recommended that he warn future anesthesiologists that he does have adverse reactions to anesthesia, so they use other drugs for future surgeries. This recommendation is in line with “personalized medicine” that Dr. Shephard discuses in her PowerPoint.

Ever since this incident on July 31st, there has been a strong odor about him, which has invaded his room and is impossible to remove with fans and opening the window. He is drinking plenty of water to flush his system, but due to his surgery, he cannot do cardiovascular exercise to expedite the process of cleansing these drugs out of his body.

UPDATE 04AUG12:
Today is the first day the odor is not detectable
(lasted 4 days).


More research into pharmacogenetics and sufferers of metabolic body odor conditions needs to be carried out, in order to help physicians develop the perfect personalized medical treatment for each individual.

María

María de la Torre
Founder and Executive Director

A Public Charity
www.meboresearch.org
www.brasil.meboresearch.org
maria.delatorre@meboresearch.org
MEBO's Blog (English)
El Blog de MEBO (español)
MEBO Brasil - Blog (Portuguese)



SUPPORT THE MEBO MISSION: Click Amazon button at right sidebar of this blog when shopping online for the holidays
at no extra cost to you.
MEBO gets small commission from Amazon.


Please use your credit card to make your donation to MEBO.


Subscribe for latest posts : Enter your email address:

Delivered by FeedBurner


A EURORDIS and NORD Member Organization

0 comments:

Post a Comment